Administration of DC vaccine 7 times, every two weeks, which quality was well controlled for three weeks culture and maturation of DCs after apheresis.

2 trials

Sponsors

Kitasato Institute Hospital, Kitasato Institute Hospital, Kitasato University

Conditions

Hepatocellular carcinoma

Phase 1

Phase I study of artificial tumor-antigens (GPC3/AFP/MAGE1) pulsed dendritic cell vaccination for patients with hepatocellular carcinoma

Active, not recruitingJPRN-UMIN000011854

Kitasato Institute HospitalHepatocellular carcinoma

Start: 2013-10-05Target: 5Updated: 2026-06-29

Phase 2

Phase II study of artificial tumor-antigens (GPC3/AFP/MAGE1) pulsed dendritic cell vaccination for patients with hepatocellular carcinoma after curative resection

Active, not recruitingJPRN-UMIN000021545

Kitasato Institute Hospital, Kitasato UniversityHepatocellular carcinoma

Start: 2016-03-22Target: 50Updated: 2026-06-29